{"name": "Valocor Therapeutics",
 "permalink": "valocor-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/valocor-therapeutics",
 "homepage_url": "http://www.valocor.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2008,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "604-295-0729",
 "description": "",
 "created_at": "Mon Jul 12 04:16:40 UTC 2010",
 "updated_at": "Wed Sep 15 00:31:24 UTC 2010",
 "overview": "\u003Cp\u003EValocor Therapeutics, Inc., a clinical stage biotech company, develops new therapies to treat dermatological conditions with unmet medical needs. Its products include Lemuteporfin, a potent and selective topical photodynamic therapy approach to sebaceous gland targeting for severe acne; VAL-001, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; VAL-002, a small-molecule kinase-inhibitor for topical treatment of chronic inflammatory skin diseases; and VAL-003, a Kinase inhibitor with dual melanin-stimulating and immune-modulating activities. Valocor Therapeutics, Inc. was founded in 2008 and is based in Vancouver, Canada.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       85],
      "assets/images/resized/0010/1597/101597v2-max-150x150.jpg"],
     [[250,
       142],
      "assets/images/resized/0010/1597/101597v2-max-250x250.jpg"],
     [[450,
       256],
      "assets/images/resized/0010/1597/101597v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Daniel",
      "last_name": "Wattier",
      "permalink": "daniel-wattier",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2010,
    "funded_month": 5,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Matrix Asset Management",
         "permalink": "matrix-asset-management",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0010/2646/102646v1-max-150x150.jpg"],
             [[250,
               50],
              "assets/images/resized/0010/2646/102646v1-max-250x250.jpg"],
             [[256,
               52],
              "assets/images/resized/0010/2646/102646v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "777 Dunsmuir Street",
    "address2": "Suite 1300",
    "zip_code": "V7Y 1K2",
    "city": "Vancouver, BC",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}